Abstract Bronchial asthma is a chronic airway condition affecting about 10%–12% of adults and 15% of children worldwide. Treatment guidelines vary by asthma nature and severity. This study aimed to elaborate on different treatments and strategies for asthmatic patients and identify new treatment options for suboptimal, controlled, or uncontrolled cases of asthma. A literature review on asthma was conducted using MedLine, PubMed, Google Scholar, EBSCO, ScienceDirect, and Scopus. Data collection followed COOPED guidelines. The search used terms “asthma,” “controller,” “reliever,” “LABAs,” “SABAs,” and “leukotrienes.” Online and offline publications were used to gather information. Bronchial asthma is a chronic airway disorder characterized by wheezing, breathlessness, chest tightness, and cough. Nonpharmacotherapy and pharmacotherapy are effectively used in all asthma stages. Bronchial asthma is often poorly controlled, and 5% of cases resist conventional therapy. Mortality occurs in cases of exacerbation and frequent bronchodilator use without corticosteroids. The pragmatic approach differs based on the nature and severity of asthma. Stepwise therapies are among the most common therapeutic strategies for asthma management. Further trials are being conducted to identify new chemical entities that work on a single common pathway in asthma pathogenesis with possible minimum adverse effects.
Hafiz et al. (Tue,) studied this question.